Related Experiment Video
Updated: Jul 17, 2026
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection
Eric S Rosenberg1, Marie Davidian, H Thomas Banks
1Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. erosenberg1@partners.org
Drug and Alcohol Dependence
|February 6, 2007
Summary
Mathematical models can optimize adaptive treatment strategies for diseases like HIV. This approach aids in designing structured treatment interruptions for better long-term viral suppression.
Area of Science:
- Mathematical modeling
- Computational biology
- Infectious disease dynamics
Background:
- Highly active antiretroviral therapies (HAART) have advanced HIV management but present challenges like cost, toxicity, drug resistance, and adherence issues, particularly in substance users.
- Structured or supervised treatment interruption (STI) strategies, involving cycles of treatment withdrawal and re-initiation, are being explored to mitigate HAART's drawbacks.
- Adaptive treatment strategies are considered the most promising approach within STI frameworks.
Purpose of the Study:
- To propose the use of mathematical models for designing adaptive treatment strategies.
- To demonstrate the application of these models in optimizing treatment for human immunodeficiency virus type-1 (HIV) infection.
- To advocate for the integration of mathematical modeling in clinical studies for developing novel therapeutic approaches.
Main Methods:
- Developing mathematical models to represent the biological mechanisms of HIV-immune system interaction over time.
- Applying control theory methods to these mathematical models.
- Designing adaptive structured treatment interruption (STI) strategies aimed at long-term viral suppression.
Main Results:
- The study outlines how mathematical models can simulate HIV dynamics within a patient.
- Control methods applied to these models can inform the design of adaptive STI strategies.
- These strategies aim to balance viral suppression with reduced treatment burden and toxicity.
Conclusions:
- Mathematical models offer a powerful framework for designing adaptive treatment strategies.
- Adaptive STI strategies, informed by mathematical modeling, show potential for improved HIV management.
- The approach can be generalized to other diseases where biological processes can be mathematically represented.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:25Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...